Literature DB >> 16941631

Vasomodulation of skeletal muscle BOLD signal.

Daniel P Bulte1, Jeff Alfonsi, Sonya Bells, Michael D Noseworthy.   

Abstract

PURPOSE: To evaluate whether the BOLD signal from skeletal muscle can be modulated by exercise and ingestion of vasoactive substances.
MATERIALS AND METHODS: The right calf muscles of healthy adult volunteers were imaged using a GE 1.5-Tesla scanner and a gradient-echo sequence with spiral readout. Time-varying changes in the BOLD signal were induced through cyclic phases of normoxia (90 seconds of 20.8% O2) and hyperoxia (45 seconds of 100% O2 at 22 L/minute). Superimposed on this paradigm were pre- and post-exercise regimes, with and without ingestion of caffeine (100 mg) or antihistamine (4 mg chlorpheniramine). The numbers of voxels within slow-twitch (soleus) and fast-twitch (gastrocnemius) muscles that significantly responded to the paradigms were scored and compared using the AFNI software (NIMH).
RESULTS: Cycling-inspired O2 produced a corresponding BOLD modulation that increased in magnitude with exercise. Chlorpheniramine significantly (P<0.01) prevented the overall increase in exercise-induced soleus muscle BOLD signal, while caffeine accentuated the increase (P<0.05) in the gastrocnemius relative to control (no vasomodulator) conditions.
CONCLUSION: BOLD signal changes with exercise can be modulated by standard doses of chlorpheniramine (antihistamine) and caffeine. We suggest that chlorpheniramine may act detrimentally on slow-twitch muscle contractility, while caffeine appears to improve fast-twitch muscle function. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941631     DOI: 10.1002/jmri.20690

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

Review 1.  Clinical implications of skeletal muscle blood-oxygenation-level-dependent (BOLD) MRI.

Authors:  Sasan Partovi; Sasan Karimi; Bjoern Jacobi; Anja-Carina Schulte; Markus Aschwanden; Lisa Zipp; John K Lyo; Christof Karmonik; Matthias Müller-Eschner; Rolf W Huegli; Georg Bongartz; Deniz Bilecen
Journal:  MAGMA       Date:  2012-02-29       Impact factor: 2.310

Review 2.  Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Britta Maurer; Ulrich A Walker
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

Review 3.  Assessing the end-organ in peripheral arterial occlusive disease-from contrast-enhanced ultrasound to blood-oxygen-level-dependent MR imaging.

Authors:  Markus Aschwanden; Sasan Partovi; Bjoern Jacobi; Nathan Fergus; Anja-Carina Schulte; Mark R Robbin; Deniz Bilecen; Daniel Staub
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

4.  Detecting gas-induced vasomotor changes via blood oxygenation level-dependent contrast in healthy breast parenchyma and breast carcinoma.

Authors:  Tess E Wallace; Andrew J Patterson; Oshaani Abeyakoon; Reem Bedair; Roido Manavaki; Mary A McLean; James P B O'Connor; Martin J Graves; Fiona J Gilbert
Journal:  J Magn Reson Imaging       Date:  2016-02-21       Impact factor: 4.813

5.  Impact of physiological noise correction on detecting blood oxygenation level-dependent contrast in the breast.

Authors:  Tess E Wallace; Roido Manavaki; Martin J Graves; Andrew J Patterson; Fiona J Gilbert
Journal:  Phys Med Biol       Date:  2016-12-14       Impact factor: 3.609

6.  Impaired skeletal muscle microcirculation in systemic sclerosis.

Authors:  Sasan Partovi; Anja-Carina Schulte; Markus Aschwanden; Daniel Staub; Daniela Benz; Stephan Imfeld; Björn Jacobi; Pavel Broz; Kurt A Jäger; Martin Takes; Rolf W Huegli; Deniz Bilecen; Ulrich A Walker
Journal:  Arthritis Res Ther       Date:  2012-10-04       Impact factor: 5.156

7.  Reduced T2* values in soleus muscle of patients with type 2 diabetes mellitus.

Authors:  Chun S Zuo; Young-Hoon Sung; Donald C Simonson; Erin Habecker; Jian Wang; Charlotte Haws; Rosemond A Villafuerte; Michael E Henry; Robert L Dobbins; Rebecca J Hodge; Derek J R Nunez; Perry F Renshaw
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.